 |
PDBsum entry 3mpm
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
New pyrazolo[1,5a]pyrimidines as orally active inhibitors of lck.
|
 |
|
Authors
|
 |
N.Gommermann,
P.Buehlmayer,
A.Von matt,
W.Breitenstein,
K.Masuya,
B.Pirard,
P.Furet,
S.W.Cowan-Jacob,
G.Weckbecker.
|
 |
|
Ref.
|
 |
Bioorg Med Chem Lett, 2010,
20,
3628-3631.
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
A novel series of pyrazolo[1,5a]pyrimidines was optimized to target
lymphocyte-specific kinase (Lck). An efficient synthetic route was developed and
SAR studies toward activity and selectivity are described, leading to Lck
inhibitors with enzymatic, cellular and in vivo potency.
|
 |
|
|
|
|
 |